glp-1 receptor agonists and cardiovascular outcome trials an update Kidney Outcomes Among Patients With CKD Receiving Agonists: A Systematic Review and Meta-Analysis of Randomized Beyond Blood Sugar: A Scoping
Description
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes
A.HolmJ
The enhanced cardiac outcome of conjugated SGLT2 inhibitors and GLP-1RA therapy in diabetic patients
As such, it is not surprising when unintended consequences of chronic receptor activation emerge
Poulter, S
Two of the most talked-about medications in this area are Mounjaro and Ozempicboth injectable treatments that have demonstrated impressive results in clinical studies
00203-5/asset/a0abd16a-3eaa-4d78-990d-ba94939c04c6/main.assets/gr2_lrg.jpg)
